Edgewood Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-114,751
Closed -$16.8M 68
2019
Q1
$16.8M Sell
114,751
-5,960,776
-98% -$864M 0.06% 26
2018
Q4
$812M Buy
6,075,527
+260,165
+4% +$42.6M 3.34% 19
2018
Q3
$1.11B Buy
5,815,362
+86,971
+2% +$16M 3.7% 15
2018
Q2
$955M Buy
5,728,391
+144,282
+3% +$23.2M 3.47% 19
2018
Q1
$940M Buy
5,584,109
+1,092,584
+24% +$183M 3.75% 17
2017
Q4
$735M Buy
4,491,525
+45,601
+1% +$8.18M 3.2% 20
2017
Q3
$911M Buy
4,445,924
+869,248
+24% +$202M 4.19% 13
2017
Q2
$869M Buy
3,576,676
+872,465
+32% +$205M 4.26% 11
2017
Q1
$646M Buy
2,704,211
+178,055
+7% +$41.5M 3.6% 19
2016
Q4
$531M Buy
+2,526,156
New +$523M 3.49% 18
2016
Q2
Sell
-2,236
Closed -$599K 80
2016
Q1
$599K Sell
2,236
-1,457,343
-100% -$417M ﹤0.01% 49
2015
Q4
$456M Buy
1,459,579
+143,657
+11% +$42.8M 3.38% 17
2015
Q3
$358M Buy
1,315,922
+39,721
+3% +$12.2M 3.02% 17
2015
Q2
$387M Buy
1,276,201
+67,022
+6% +$20M 3.22% 16
2015
Q1
$360M Buy
+1,209,179
New +$345M 3.22% 17

Other funds holding AGN

Edgewood Management's AGN Position: Q2 2019 in Review

Edgewood Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 114,751 shares — an estimated $16.8M sold.

Edgewood Management first reported a position in AGN in Q1 2015 and held it in 15 quarters. The position peaked at $1.11B in Q3 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Edgewood Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Edgewood Management sold 114,751 Allergan plc shares in Q2 2019, an estimated $16.8M.
  • Edgewood Management first reported a position in Allergan plc in Q1 2015 and held it in 15 quarters.
  • Edgewood Management's Allergan plc position peaked at $1.11B in Q3 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Edgewood Management's 13F filing for Q2 2019, filed 12 Aug 2019.